Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
Chapter 2 Executive Summary
2.1 Autoinjectors Market, by Devices, 2015 (USD Mn)
2.2 Autoinjectors Market Share, by Therapeutic Area, 2015 (Value %)
2.3 Autoinjectors Market Share, by Geography, 2015 (Value %)
Chapter 3 Autoinjectors Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 Drivers
3.3 Challenges
3.4 Opportunities
3.5 Major Market Events Assessment
3.6 Attractive Investment Proposition
3.7 Competitive Analysis: Autoinjectors Market, by Key Market Players
Chapter 4 Global Autoinjectors Market Analysis, by Devices, 2013 – 2022 (USD Mn)
4.1 Preface
4.2 Manual Injection Autoinjectors
4.3 Automated Injection Autoinjectors
4.4 Reusable Autoinjectors
4.5 Disposable Autoinjectors
4.6 Variable Dose Autoinjectors
4.7 Smart Autoinjectors
Chapter 5 Global Autoinjectors Market Analysis, by Therapeutic Area, 2013 – 2022 (USD Mn)
5.1 Preface
5.2 Anaphylaxis
5.3 Anticoagulants
5.4 Autoimmune Diseases
5.5 Emergency Medicine
5.6 Infectious Diseases
5.7 Hematopoietics
5.8 Hormones
5.9 Neurology
5.10 Reproductive Health
Chapter 6 Global Autoinjectors Market Analysis, by Geography, 2013 – 2022 (USD Mn)
6.1 Preface
6.2 North America
6.2.1 United States
6.2.2 Canada
6.3 Europe
6.3.1 United Kingdom
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia Pacific
6.4.1 Japan
6.4.2 China
6.4.3 Rest of Asia Pacific
6.5 Middle East and Africa (MEA)
6.6 Latin America
Chapter 7 Company Profiles
7.1 Biogen Idec, Inc.
7.1.1 Business Description
7.1.2 Financial Health and Budget Allocation
7.1.3 Product Positions/Portfolio
7.1.4 News Coverage
7.2 Becton, Dickinson and Company
7.2.1 Business Description
7.2.2 Financial Health and Budget Allocation
7.2.3 Product Positions/Portfolio
7.2.4 News Coverage
7.3 Antares Pharma, Inc.
7.3.1 Business Description
7.3.2 Financial Health and Budget Allocation
7.3.3 Product Positions/Portfolio
7.3.4 News Coverage
7.4 Mylan, Inc.
7.4.1 Business Description
7.4.2 Financial Health and Budget Allocation
7.4.3 Product Positions/Portfolio
7.4.4 News Coverage
7.5 Novartis International AG
7.5.1 Business Description
7.5.2 Financial Health and Budget Allocation
7.5.3 Product Positions/Portfolio
7.5.4 News Coverage
7.6 Unilife Corporation
7.6.1 Business Description
7.6.2 Financial Health and Budget Allocation
7.6.3 Product Positions/Portfolio
7.6.4 News Coverage
7.7 Pfizer, Inc.
7.7.1 Business Description
7.7.2 Financial Health and Budget Allocation
7.7.3 Product Positions/Portfolio
7.7.4 News Coverage
7.8 Scandinavian Health Ltd.
7.8.1 Business Description
7.8.2 Financial Health and Budget Allocation
7.8.3 Product Positions/Portfolio
7.8.4 News Coverage
7.9 Ypsomed Holding AG,
7.9.1 Business Description
7.9.2 Financial Health and Budget Allocation
7.9.3 Product Positions/Portfolio
7.9.4 News Coverage
7.10 Sanofi S. A.
7.10.1 Business Description
7.10.2 Financial Health and Budget Allocation
7.10.3 Product Positions/Portfolio
7.10.4 News Coverage
7.11 Bayer AG
7.11.1 Business Description
7.11.2 Financial Health and Budget Allocation
7.11.3 Product Positions/Portfolio
7.11.4 News Coverage
7.12 Emergent BioSolutions
7.12.1 Business Description
7.12.2 Financial Health and Budget Allocation
7.12.3 Product Positions/Portfolio
7.12.4 News Coverage
7.13 Other Notable Payers
List of Figures
FIG. 1 Autoinjectors: Market Segmentation
FIG. 2 Autoinjectors Market, by Devices, 2015 (USD Mn)
FIG. 3 Autoinjectors Market, by Therapeutic Area, 2015 (Value %)
FIG. 4 Autoinjectors Market Share, by Geography, 2015 (Value %)
FIG. 5 Attractive Investment Proposition, Autoinjectors Market, 2015
FIG. 6 Competitive Analysis: Autoinjectors Market, by Key Market Players
FIG. 7 Global Manual Injection Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 8 Global Automated Injection Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 9 Global Reusable Autoinjectors Market, 2014-2022 (USD Mn)
FIG. 10 Global Disposable Autoinjectors Market, 2014-2022 (USD Mn)
FIG. 11 Global Variable Dose Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 12 Global Smart Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 13 Global Anaphylaxis Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 14 Global Anticoagulants Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 15 Global Autoimmune Diseases Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 16 Global Emergency Medicine Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 17 Global Infectious Diseases Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 18 Global Hematopoietic Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 19 Global Hormone Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 20 Global Neurology Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 21 Global Reproductive Health Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 22 United States Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 23 Canada Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 24 United Kingdom Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 25 Germany Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 26 Rest of Europe Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 27 Japan Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 28 China Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 29 Rest of Asia Pacific Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 30 Middle East and Africa Autoinjectors Market, 2013 – 2022 (USD Mn)
FIG. 31 Latin America Autoinjectors Market, 2013 – 2022 (USD Mn)
List of Tables
TABLE 1 Global Autoinjectors Market, by Devices, 2013 – 2022 (USD Mn)
TABLE 2 Global Autoinjectors Market, by Therapeutic Area, 2013 – 2022 (USD Mn)
TABLE 3 Global Autoinjectors Market, by Geography, 2013 – 2022 (USD Mn)
TABLE 4 North America Autoinjectors Market, by Country, 2013 – 2022 (USD Mn)
TABLE 5 Europe Autoinjectors Market, by Country, 2013 – 2022 (USD Mn)
TABLE 6 Asia Pacific Autoinjectors Market, by Country, 2013 – 2022 (USD Mn)